首页 | 本学科首页   官方微博 | 高级检索  
     


Effect of human erythropoietin (hEPO) treatment on anemia in ICR-derived glomerulonephritis (ICGN) mice.
Authors:Yohei Miyamoto  Keiko Kuramitsu-Miyamoto  Ema Iwanaga  Kozue Uchio-Yamada  Misuzu Yamaguchi-Yamada  Atsuo Ogura  Noboru Manabe
Affiliation:Toxicology Laboratory, Pharmaceutical Research Laboratories, Toray Industries, Inc., Kanagawa, Japan.
Abstract:ICR-derived glomerulonephritis (ICGN) mice are a novel inbred strain with hereditary nephrotic syndrome and are thus considered a good animal model of human idiopathic nephrotic syndrome. In the present study, we investigated the effect to erythrocyte production by human erythropoietin (hEPO) treatment in ICGN mice during the early nephrotic stage. Erythrocyte count, hemoglobin concentration and hematocrit value in hEPO-treated (5 U/body/day, for 5 days) ICGN mice were recovered to the levels found in normal ICR mice. In addition, there was no correlation between plasma creatinine level, a marker of renal function, and erythrocyte count after hEPO treatment. Therefore, anemia in ICGN mice may be caused by decreased production of EPO in the kidney following progressive parenchymal damage.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号